Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Danni Hewson, head of financial analysis at AJ Bell, said: ‘Drug companies have learned their lesson from patent cliffs that they cannot rely on blockbuster treatments forever.
‘They need to keep the pipeline stocked up, acting like a conveyer belt so something else comes along just as an existing treatment loses patent protection and earnings fall victim to generic copycats.
‘Medicine is constantly evolving and today’s patient is hyper-aware of the next big development that could make their treatment more successful and less invasive.’
https://www.thisismoney.co.uk/money/markets/article-13215881/AstraZeneca-boss-ramps-buying-spree-Drugs-giant-2bn-bid-Canadian-cancer-specialist.html
Stifle and Investec are brokers. They buy and sell our shares when we ask them to buy and sell. Their trades are irrelevant.
Assuming it was this yesterday, but I could just as well be talking BLX:
19-Mar-24 15:52:47 34.5751 24,678 Sell* 34.00 36.00 8,532
RE: the sell - not sure why they would sell but it seems a tiny amount of money unless I'm mistaken c£8K...?
If it is that figure, that's a drop in the ocean and doesn't matter a hill of beans
If this sp is going up why would Stifel sell at 35?
I'd be really happy with the lowest analyst target, which appears to be 87p.....but I haven't held that long. I'll be VERY happy with £2. I guess it depends on the big shareholders and the company management what gets agreed or not.
It won't be suspended until the bidding process ends. It will take 3 months from the time the company announces offers. Bids can keep coming in throughout the process.
The consultation process ends on Friday. We'll get their recommendations after that. That's why all these iis have bought in substantially. We might get a bit of a bidding scrum from big pharma. The main suppliers for chronic kidney disease drugs at the moment are AstraZeneca and Thermo Fischer. Not to say that others might not want to take this test. It's worth billions potentially in it's own right. 10 million Americans have diabetes 2. Around 89 million people worldwide also have it. At $950.00 a test it's a valuable product. I think it will go for £2.00.
The talk of suspension is related to a takeover offer, not the company going pop. RENX has staved off pop by the recent issue. The company needs to now emphasise its attractiveness and we could see some nice meaty offers come in over the next few months. GLA
Why the company will be suspended if they done successfully placing for 10 millions?
Subtle. 🙄
Does anybody know what will happen to the shares once the company is is suspended? Will all the shareholders still holding RENX shares lose them? Thank you
No holdings rns today as we have had many over the last couple of weeks.
Unless they are happy with what they have of course?
It was opened at the wrong price. I was going to buy at 32.5p but from the bell it was 36.4p to buy so I didn't bother. It looks like no one else bothered either - or just a few took small punts. If it had opened at 32.5p there would have been a flurry of buying and it would probably be up around the 40p mark by now.
Let's see if we can match the U.S today and see what they do thos afternoon.
Institutions are certainly loading up here so follow the money as can't be long before we are suspended and a buy out offer comes in.
Surprised by the lack of movement here
Recent Pharma/PE deals have included a deferred element….I would not be surprised to see much of the value over the current company value offered as a 2 year warrant payable on certain performance metrics.
Differences in the timing of any takeover payments may be significant as may be the value….
The current mcap is around £40m
What would you take of these options:
£80m upfront?
£60m upfront and 60m deferred?
£40m upfront and 200m deferred?
When they suspend it here, people won't be able to buy again. Shareholders will simply vote on sale price and going by the information available its in excess of £1.40.
Corporations know this hence buying all they can. Simply transferring the stock from the weak holders to the companies.
A great watch.
32.5% up at $1.15 - that's 45p equivalent - with 30 minutes to go to close.
I am getting the price from my IG account which includes US stocks. Ii is also available on Yahoo Finance under the ticker RNLX - link below.
https://uk.finance.yahoo.com/quote/RNLX?.tsrc=fin-srch
25% up currently
Have you a link please?
Thankyou in advance.
US up over 20% now at 7pm GMT. Over 40p equivalent if it continues to closing.
Not suspended. It will be when they consider the offers.
Suspended why?
Dont forget -
RNS Number : 4140F
Renalytix PLC
04 March 2024
Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care provides the following update in regard to an unsolicited approach from a possible strategic acquiror, launch of a Formal Sale Process, and its advanced financing activities.
Formal Sale Process
Renalytix has received an unsolicited approach from a large and well-capitalised publicly listed strategic diagnostics company, which is in the process of evaluating an acquisition of the entire issued, and to be issued, share capital of the Company.
Therefore, the Company has commenced a review of all available options, including a possible sale of the Company and/or its assets, and has commenced a formal sale process (as referred to in Note 2 on Rule 2.6 of the City Code on Takeovers and Mergers) (the "Formal Sale Process"). The Formal Sale Process will enable the Board and its advisers to conduct an orderly process and engage more widely with all potentially interested parties, with a view to optimising the outcome for Renalytix's shareholders. It remains possible that, following completion of the Formal Sale Process, the Board will consider that Renalytix and its shareholders would be best served by alternative strategic options available to the Company, including by Renalytix continuing to trade on AIM and Nasdaq as an independent entity.